Hot Products

Sylvestroside I
Catalog No: CFN97081

Sylvestroside I may have analgesic effect.

Symlandine
Catalog No: CFN00261

Symlandine, 7-acetylintermedine, and 7-acetyllycopsamine are pyrrolizidine alkaloids, isolated from comfrey, can produce hepatotoxicity in livestock and humans and carcinogenicity in experimental animals.

Symphytine
Catalog No: CFN00262

Symphytine and senkirkine, the pyrrolizidine alkaloids, have carcinogenicity.

Synephrine
Catalog No: CFN99551

p-Synephrine is widely used in weight loss and weight management as well as in sports performance products, which has antidepressant-like effects in the murine models of forced swimming and tail suspension, it also exerts potent anti-inflammatory effects by inhibition of the NF-κB signaling pathway. Synephrine inhibits eotaxin-1 expression via the STAT6 signaling pathway.

Syringaldehyde
Catalog No: CFN99421

4-Hydroxy-3,5-dimethoxybenzaldehyde is an organic compound that occurs naturally in trace amounts, it possesses powerful antioxidant activity, in minimizing DNA damage, and activating survival signal Akt pathway, and it may be of value in the development of radioprotective compounds. It is used in pharmaceuticals, food, cosmetics, textiles, pulp and paper industries, and even in biological control applications.

Syringalide A 3'-rhamnoside
Catalog No: CFN95739

Syringaresinol
Catalog No: CFN92060

(-)-Syringaresinol may be a potential chemotherapeutic agent for the treatment of cancer; it against H/R-induced cardiomyocyte injury and death, the degradation of HIF-1α through activation of FOXO3 is a potential therapeutic strategy for ischemia-related diseases. Syringaresinol induces vasorelaxation by enhancing NO production in endothelial cells via two distinct mechanisms, phosphatidylinositol 3-kinase/Akt- and PLC/Ca(2+)/CaMKKβ-dependent eNOS phosphorylation and Ca(2+)-dependent eNOS dimerization.

Syringaresinol diacetate
Catalog No: CFN98009

Reference standards.

Syringaresinol-di-O-glucoside
Catalog No: CFN90458

Syringaresinol-di-O-glucoside protects the animals from the stress-induced decreases in sex behaviours and in rectal temperature, the stress-induced failure of retrieval of memory, and the stress-induced enlargement of adrenal gland.

Syringetin
Catalog No: CFN70363

Syringetin prevents and treats bone metastasis in patients with lung cancer, it can directly inhibits osteoclastogenesis and reverses lung adenocarcinoma‑mediated osteoclastogenesis. Syringetin can increase BMP-2 synthesis, and subsequently activate SMAD1/5/8 and ERK1/2, and this effect may contribute to its action on the induction of osteoblast maturation and differentiation, followed by an increase of bone mass.